BioPharma Dive 21 nov. 2025 GSK, Anaptysbio sue each other over Jemperli revenue #Jemperli revenue #royalty business
BioPharma Dive 20 nov. 2025 Moderna secures $1.5B lifeline as it looks to break even in 2028 #Moderna secures #day event